Well here are some facts for you to digest. At $200.00 a share this company was not expected to survive. They would absolutely have gone bankrupt except for two very important things. 1. The investors both small and large made it possible for them to have the money to finish their clinical trials. 2. They surely would not have lasted three to five years to complete their clinical trials had Trump not allowed the Emergency Use fast track that also saved them from failing. Yes us shareholders should be rewarded. Everytime there is a spike in the price the insiders help themselves to the majority of the profits and the share price drops immediately after. They are always first at the table feeding their greedy selves number one. Bancel and the rest of them have made millions each in just the last month alone where they can buy shares for $12.00 each and sell them the very same day for $400.00 or more. Nice deal.
News 
Market Data 
Discover 
